Literature DB >> 16988028

Triptan migraine treatments and antidepressants: risk of serotonin syndrome.

Eric Wooltorton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16988028      PMCID： PMC1586097          DOI： 10.1503/cmaj.061217

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

Review 1.  Serotonin syndrome: a brief review.

Authors:  Philippe Birmes; Dominique Coppin; Laurent Schmitt; Dominique Lauque
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

Review 2.  The serotonin syndrome.

Authors:  Edward W Boyer; Michael Shannon
Journal:  N Engl J Med       Date:  2005-03-17       Impact factor: 91.245

Review 3.  Identifying serotonin syndrome in the emergency department.

Authors:  Richard C Christensen
Journal:  Am J Emerg Med       Date:  2005-05       Impact factor: 2.469

4.  Serotonin syndrome: not a benign toxidrome.

Authors:  Sarah Garside; Patricia I Rosebush
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262
  4 in total
  2 in total

1.  The pharmacological management of migraine, part 2: preventative therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-08

2.  The pharmacological management of migraine, part 1: overview and abortive therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.